Introduction
Postural instability (PI) is known to be a levodopa-resistant characteristic of advanced idiopathic Parkinson's disease (IPD) that worsens with disease progression [1] [2] [3] . High frequency deep brain stimulation of the globus pallidus internus (GPI-DBS) has been shown to elicit significant anti-parkinsonian effects superior to best medical therapy reducing tremor, bradykinesia and rigidity, and suppressing levodopa-induced dyskinesias [4] [5] [6] [7] [8] .
Historically, studies evaluating the effects of DBS and levodopa (L-DOPA) on postural stability have used clinical rating scales, including the Postural Instability and Gait Disorder (PIGD) component of the Unified Parkinson's Disease Ratings Scale (UPDRS). GPI stimulation in combination with levodopa has been shown to improve PIGD scores [9] , as well as alleviating the other cardinal signs of IPD [10] . Most recently, the combined effect of medication and DBS was found to improve subjective balance and gait scores more than either therapy alone [11] .
However, the subjective nature of the PIGD and similar rating scales, and its questionable specificity and sensitivity compared to more quantitative measures of PI [3, 12] raises questions as to its utility as a measure of postural stability. To date there have been few quantitative studies assessing the effects of DBS, in particular the interactive effects between DBS and levodopa, and these have included only small numbers of GPI-DBS patients [3, [13] [14] [15] .
Quantitative posturography provides a more precise measure of postural stability than the commonly used clinician-rated balance assessments. Using a range of quantifiable measures, such as sway path area and length, a more detailed analysis of changes in postural control with 3 treatment and disease progression is achievable [16] [17] [18] [19] [20] . Moreover, dynamic posturographic measures allow IPD patients who fall to be discriminated from non-fallers [18] .
In this study we used static and dynamic posturography to objectively assess the short-term effects on PI of GPI-DBS and L-DOPA, individually and in combination, in a group of patients with advanced IPD with GPI stimulators. An understanding of how the two treatment modalities interact is important as most patients with implanted stimulators still require ongoing treatment with L-DOPA and other dopaminergic medications.
Subjects and Methods

Subjects
Ten IPD patients (7 males; mean age 58.8±5.6 years; mean disease duration 13.4±5. Centre of pressure (CoP) acquisitions were made during static standing and dynamic balance tasks. During the static standing task, the patient maintained visual fixation on a cross projected at eye level at a distance of 1 metre while standing as still as possible for 60 seconds with arms by their sides (EO condition). This task was repeated with the eyes closed (EC condition). The task was performed twice for each condition, with a 2-minute seated rest period between tasks.
The dynamic assessment task was designed to assess the ability to move the CoP as rapidly and accurately as possible to a number of eccentric positions with respect to the BoS Centre and to maintain this position for a 1 sec period. Real-time CoP position relative to the BoS perimeter was displayed at a distance of 1 metre from the subject on a 24-inch computer monitor adjusted to eye level. Circular targets were programmed to appear in random order at one of 8 eccentric positions on the screen (0°, 45°, 90°, 135°, 180°, 225°, 270° and 315° relative to the vertical).
Based on previous experience with such studies [18, 19] 
Results
The results of the static and dynamic posturography for the IPD patients and Control subjects are summarised in Figure 1 and Table 3 .
Static posturography
Two-way repeated-measures ANOVA showed a significant within-condition effect for both Sway in the L-DOPA condition compared to the OFF condition, but was significantly reduced by DBS+L-DOPA compared to L-DOPA alone (p<0.05). Target Overshoot was significantly increased in the L-DOPA condition compared to the OFF condition and Control subjects (680%, p<0.05). This increase was partially reversed in the DBS+L-DOPA condition, though it was still significantly greater compared to the OFF condition and Control subjects. In the L-DOPA condition there was also a marked increase and increased variability in Wandering compared to the OFF condition and Control subjects (p<0.05), which did not occur with DBS+L-DOPA. There were no significant changes in Average Speed for any of the conditions.
UPDRS Scores
There were significant improvements in the UPDRS motor, tremor and axial scores in both the L-DOPA (p<0.05) and DBS conditions (p<0.05), and there was a trend towards a greater improvement in the DBS+L-DOPA condition, although this was not statistically significant.
Regression analysis found no significant correlations existed between UPDRS scores and Sway
Area or Sway Path Length, but showed a significant correlation between the AIMS score in the L-DOPA condition and Sway Area (p=0.02), Target Achievement Time (p=0.02), Wandering (p=0.04) and Target Overshoot (p=0.01).
Discussion
This is the largest study of postural control in IPD patients with GPI stimulators using quantitative posturography, and of the interactive effects of GPI-DBS and levodopa. The aim of the study was to better characterise the short-term effects of levodopa and GPI-DBS on objective measures of static and dynamic postural stability, with particular attention to changes between the standard 4-state post-DBS treatment assessment protocol. Novel aspects of the study were the application of a multidirectional dynamic leaning task to assess whole body postural control, and the finding that GPI-DBS improved the spatial accuracy and directional 9 control of the task when administered during the levodopa ON state. Our findings also confirm previous observations in smaller numbers of patients that GPI-DBS reduces sway during stance and abrogates the increase in sway which occurs on levodopa [3, 14] .
The findings provide further evidence for the differential effects and mode of action of levodopa and GPI-DBS [3, 14, 22] and show that the two treatment modalities affect temporal and spatial aspects of postural control in different ways. Thus, levodopa had a greater effect on movement 'Start Time' but reduced the spatial accuracy of the leaning task, as shown by the increase in 'Target Overshoot' and 'Wandering' parameters, and increase in 'Target Achievement Time' in the L-DOPA condition. In contrast, GPI-DBS had less of an effect on 'Start Time' but improved the accuracy of the leaning movements, partially reversing the adverse effects of levodopa on 'Target Overshoot' and 'Wandering'. Previous studies concluded that dyskinesias were not the primary cause of the deterioration in postural stability which occurs in the L-DOPA condition [3, 14] . In the present study we found that although dyskinesias were only minor or absent at the time of testing, there was a statistical correlation between the dyskinesia rating scale immediately prior to testing and some posturographic measures. It is possible therefore that clinically inapparent dykinesias may have contributed to the increase in sway and impaired accuracy of the dynamic leaning task in the L-DOPA condition in at least some patients, and that the improvement in these parameters in the DBS+L-DOPA state may have been due in part to suppression of dyskinesias. The observation that these parameters were abnormal even in some patients without any obvious dyskinesias (i.e. an AIMS score of 0) suggests that other factors are probably also involved. The possibility also needs to be considered that dyskinesias may have contributed to the faster 'Start time' in the L-DOPA condition. Further studies of larger numbers of patients with and without dyskinesia are needed to confirm the present findings and to clarify the contribution of minor dyskinesias to impaired dynamic postural control. Another explanation which has been suggested previously for the increased sway on levodopa is that it is due to reduced tone and stiffness in the postural muscles and to impaired somatosensory feedback [3] .
There have been relatively few studies of the effects of GPI-DBS on postural control in IPD and more studies of subthalamic nucleus (STN) stimulation. The preferred target for improvements in PIGD remains unclear [23] . Although some studies have suggested that GPI-DBS is less effective than STN stimulation for axial symptoms [24] , a recent randomised double-blind study comparing the outcomes after stimulation at the two sites found that balance confidence and clinical balance scores were superior with GPI-DBS [11] . In addition, a meta-regression analysis of long-term studies suggested that GPI-DBS may provide more sustained benefit in preventing long-term decline in PIGD [10] . The mechanisms by which GPI-DBS improves postural control are uncertain, but it has been suggested that it may be due to descending effects on the pedunculopontine nucleus or other non-dopaminergic centres in the mesencephalic locomotor area [25] . Previous posturographic studies have shown that both GPI and STN stimulation can improve postural sway and balance reactions, including the capacity to respond to postural perturbations [9, 14, 15] , but this was not investigated in the present study. Unlike previous studies which have employed moving platforms to assess postural stability and responses to perturbations, we used a stable balance platform and assessed the speed and accuracy of a whole-body leaning task in which subjects moved their centre of gravity to eccentric positions whilst maintaining a fixed base of support [18] . This test paradigm is particularly pertinent to the maintenance of postural stability during gait initiation in IPD when the ability to maintain balance in the face of akinesia and freezing is critical to avoid falling, and we have shown previously that it allows discrimination of IPD fallers from non-fallers [18] .
Our finding of impaired spatial accuracy and targeting in the whole body dynamic leaning task has some parallels with the ataxia and dysmetria of limb movement that occurs with cerebellar lesions and suggests that there could be a subclinical impairment of cerebellar function in IPD which is aggravated by levodopa and improves with GPI-DBS. While there is no direct evidence for this, it is noteworthy that pathological changes in the cerebellum have been described in IPD, as well as MRI evidence of increased functional activation and connectivity which can be normalised by DBS of the GPI or STN [26] . Moreover, the cerebellum has also been implicated in the pathophysiology of dyskinesias, as well as tremor and other symptoms and as a potential therapeutic target in Parkinson's disease [26] . There are also parallels with the effects of DBS on postural control during other self-initiated movements such as step initiation where, contrary to the effects of L-DOPA, DBS has been shown to impair anticipatory postural adjustments [22] .
There are a number of possible limitations to this study. Firstly, although patients were not tested again for 30-60 minutes after DBS was switched off, by which time their typical DBS benefit had worn off, the possibility of some residual effects from the preceding period of DBS cannot be completely ruled out. Secondly, unlike the Control subjects, the IPD patients repeated the posturography test four times and it is possible that the test results may have been influenced by a practice effect, although the randomized sequence of testing was intended to minimise this. The possibility that longer term plasticity effects during the period that the GPI-DBS stimulators were in situ may have contributed to the short term responses and interactive effects found in this study also needs to be considered. Lastly, the AIMS scale may be too insensitive to detect minor dyskinesias and other methods for detection of dyskinesias may need to be considered in future studies.
Conclusions
The results of this study provide further evidence for the differential effects and mode of action of GPI-DBS and levodopa on balance control in longstanding IPD. There appears to be a qualitative deterioration in some aspects of postural control in chronically treated GPI-DBS patients treated with levodopa alone, which GPI-DBS seems to improve. Whether this simply relates to a reduction in axial and limb dyskinetic postural perturbance or alternative hypotheses, such as normalisation of disinhibited cerebellar processes, remains to be determined. Further studies exploring the latter hypothesis could be worthwhile and may lead to novel therapeutic strategies targeted at modulating cerebellar function to enhance motor function and postural control aspects of IPD.
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